for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Business

Sanofi extends Genzyme bid to Jan

Posted

Dec.13 - Sanofi-Aventis has decided to give shareholders of U.S. pharma Genzyme more time to consider its 69 dollar a share offer. <p>Ingrid Smith, Reuters</p>

Business

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up